Related Experiment Video
Updated: Feb 6, 2026

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
Published on: July 14, 2022
Novel targeted treatment options for advanced cholangiocarcinoma
Amit Mahipal1, Anuhya Kommalapati2, Sri Harsha Tella2
1a Department of Medical Oncology , Mayo Clinic , Rochester , MN , USA.
Introduction:
Surgical resection remains the mainstay of potentially curative treatment in the early stages of cholangiocarcinoma, whereas for the advanced stage, systemic chemotherapeutics and experimental targeted therapies are the primary treatment options. The molecular heterogeneity of the tumor is based on location, liver dysfunction, and relative rarity of the disease and confers challenges for clinical trial enrollment. The advancements in the understanding of molecular pathogenesis of cholangiocarcinoma have led to the development of targeted therapies that are currently being evaluated in the clinical trials.
Areas Covered:
This review summarizes the current understanding and future directions of targeted therapeutic options in the management of advanced cholangiocarcinoma.
Expert Opinion:
Advanced cholangiocarcinoma has a dismal prognosis; improved understanding of the molecular pathogenesis and advancements in development of targeted therapy offers hope that we may improve outcomes in this rare, but highly lethal cancer. Among the newly discovered molecular alterations, targeting FGFR2 fusions, IDH1/2 mutations and HER2 receptors hold great promise for improving the future management of cholangiocarcinoma. Immunotherapy in combination with targeted agents and chemotherapy may improve outcomes. In addition, drugs targeting the MEK, EGFR, KRAS, BRAF, and ROS1 pathways and neo-angiogenesis may also provide new horizons in the management of cholangiocarcinoma.
Insights
Targeted therapies offer new hope for advanced cholangiocarcinoma, a rare cancer. Research is exploring treatments for molecular alterations like FGFR2 fusions and IDH1/2 mutations to improve patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Cholangiocarcinoma (bile duct cancer) has limited treatment options for advanced stages.
- Tumor heterogeneity and rarity pose challenges for clinical trials and treatment development.
- Recent advancements in understanding molecular pathogenesis are driving the development of targeted therapies.
Purpose of the Study:
- To review current targeted therapeutic options for advanced cholangiocarcinoma.
- To discuss future directions and emerging treatments for this rare cancer.
Main Methods:
- Review of current literature on targeted therapies for cholangiocarcinoma.
- Analysis of molecular alterations and their therapeutic implications.
- Evaluation of ongoing clinical trials for advanced cholangiocarcinoma.
Main Results:
- Targeting FGFR2 fusions, IDH1/2 mutations, and HER2 receptors shows promise.
- Combination therapies including immunotherapy, targeted agents, and chemotherapy may improve outcomes.
- Drugs targeting MEK, EGFR, KRAS, BRAF, ROS1 pathways, and neo-angiogenesis represent future treatment avenues.
Conclusions:
- Targeted therapies represent a significant advancement in managing advanced cholangiocarcinoma.
- Personalized treatment strategies based on molecular profiling are crucial for improving prognosis.
- Further research and clinical trials are essential to realize the full potential of these novel therapies.
Related Concept Videos
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Extraction: Advanced Methods
Sample Preparation for Analysis: Advanced Techniques
Acid digestion with strong acids is commonly used to dissolve inorganic materials that are insoluble (do not dissolve) in water. This method can be useful for...
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Treatment Resistant Cancers

